Katkat

Explain Medical AI Data and Evaluation

OracleData Scientist · Technical Screen

Last updated

This question tests the ability to design an end-to-end evaluation and data pipeline for a clinical conversational agent, emphasizing safety, bias mitigation, and rigorous validation in a high-stakes environment.

The Scenario

You are tasked with building a Medical Question Answering (QA) agent for a hospital portal. The model will assist patients by answering general health queries and summarizing lab reports, but it must not provide definitive diagnoses or substitute for a doctor. You have access to a large corpus of electronic health records (EHR) notes, clinical guidelines (e.g., PubMed, UpToDate summaries), and a small set of expert-annotated Q&A pairs.

The Task

Design a robust pipeline for this system by addressing the following components:

  1. Data Strategy: How would you structure your data for training or retrieval? Specifically, how do you handle de-identification and prevent 'data leakage' where the model might memorize patient-specific info or clinical identifiers?

  2. Model Architecture: Given the sensitivity of medical data, discuss the trade-offs between fine-tuning a Large Language Model (LLM) on clinical notes versus building a Retrieval-Augmented Generation (RAG) system using trusted clinical guidelines.

  3. Evaluation Framework: Design an evaluation protocol. How would you measure 'hallucination' and 'safety'? Mention both automated metrics and the process for human-in-the-loop validation.

  4. Risk Mitigation: How do you identify and mitigate subgroup bias (e.g., the model performing differently across demographics) or distribution shift if the user's querying style differs significantly from the clinical training data?

Hints

Hint 1

Consider the difference between training on raw EHR notes versus using them for in-context retrieval and the risk of PII (Personally Identifiable Information) exposure.

Hint 2

For evaluation, think beyond standard NLP metrics like BLEU or ROUGE, focusing instead on factual consistency and clinical utility.

Hint 3

Think about how to use a 'guardrail' layer or a secondary classifier to filter out unsafe advice before it reaches the end user.

Follow-up questions

  • How would you measure the confidence or 'calibration' of the model's answers so it knows when to say 'I don't know'?
  • If the model performs well on internal benchmarks but fails in the field due to distribution shift, what monitoring steps would you implement?
  • How do you ensure reproducibility in your evaluation pipeline when using non-deterministic LLMs?